These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
607 related items for PubMed ID: 19065294
1. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication. Misumi Y, Ueda M, Fujimori H, Shinriki S, Meng W, Kim J, Saito S, Obayashi K, Uchino M, Ando Y. Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294 [Abstract] [Full Text] [Related]
2. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils. Cardoso I, Goldsbury CS, Müller SA, Olivieri V, Wirtz S, Damas AM, Aebi U, Saraiva MJ. J Mol Biol; 2002 Apr 12; 317(5):683-95. PubMed ID: 11955017 [Abstract] [Full Text] [Related]
3. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Lai Z, Colón W, Kelly JW. Biochemistry; 1996 May 21; 35(20):6470-82. PubMed ID: 8639594 [Abstract] [Full Text] [Related]
7. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Hurshman AR, White JT, Powers ET, Kelly JW. Biochemistry; 2004 Jun 15; 43(23):7365-81. PubMed ID: 15182180 [Abstract] [Full Text] [Related]
8. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Gustavsson A, Jahr H, Tobiassen R, Jacobson DR, Sletten K, Westermark P. Lab Invest; 1995 Nov 15; 73(5):703-8. PubMed ID: 7474944 [Abstract] [Full Text] [Related]
9. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis. Saito S, Ando Y, Nakamura M, Ueda M, Kim J, Ishima Y, Akaike T, Otagiri M. Biochemistry; 2005 Aug 23; 44(33):11122-9. PubMed ID: 16101296 [Abstract] [Full Text] [Related]
10. Intermolecular disulfide linkages are not required for transthyretin amyloid fibril formation in vitro. McCutchen SL, Kelly JW. Biochem Biophys Res Commun; 1993 Dec 15; 197(2):415-21. PubMed ID: 8267575 [Abstract] [Full Text] [Related]
11. Clusterin regulates transthyretin amyloidosis. Lee KW, Lee DH, Son H, Kim YS, Park JY, Roh GS, Kim HJ, Kang SS, Cho GJ, Choi WS. Biochem Biophys Res Commun; 2009 Oct 16; 388(2):256-60. PubMed ID: 19664600 [Abstract] [Full Text] [Related]
16. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization. Green NS, Palaninathan SK, Sacchettini JC, Kelly JW. J Am Chem Soc; 2003 Nov 05; 125(44):13404-14. PubMed ID: 14583036 [Abstract] [Full Text] [Related]
18. Formation of cytotoxic transthyretin is not dependent on inter-molecular disulphide bridges commonly found within the amyloid form. Lindhagen-Persson M, Vestling M, Reixach N, Olofsson A. Amyloid; 2008 Dec 05; 15(4):240-5. PubMed ID: 19065295 [Abstract] [Full Text] [Related]
19. Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin. Pasquato N, Berni R, Folli C, Alfieri B, Cendron L, Zanotti G. J Mol Biol; 2007 Feb 23; 366(3):711-9. PubMed ID: 17196219 [Abstract] [Full Text] [Related]
20. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions. Lashuel HA, Wurth C, Woo L, Kelly JW. Biochemistry; 1999 Oct 12; 38(41):13560-73. PubMed ID: 10521263 [Abstract] [Full Text] [Related] Page: [Next] [New Search]